Sutro Biopharma

Filed a patent for "sting agonist compounds and conjugates" on Mon, July 31, 2023

Filed a patent for "rf1 ko e. coli strains" on Mon, April 3, 2023

Filed a patent for "anti-bcma antibodies and treatment methods" on Thu, November 7, 2024

Filed a patent for "anti-folate receptor conjugate combination therapy with bevacizumab" on Fri, November 17, 2023

Filed a patent for "hemiasterlin derivatives for conjugation and therapy" on Thu, August 1, 2024

Filed a patent for "interleukin-2-prodrugs" on Thu, June 16, 2022

Filed a patent for "beta-glucuronide linker-payloads, protein conjugates thereof, and methods thereof" on Mon, June 27, 2022

Filed a patent for "e. coli strains having an oxidative cytoplasm" on Thu, January 5, 2023

Filed a patent for "il-12 mutants with reducted toxicity, compositions thereof and methods of using the same" on Fri, July 1, 2022

Filed a patent for "anti-ror1 antibody conjugates, compositions comprising anti-ror1 antibody conjugates, and methods of making and using anti-ror1 antibody conjugates" on Fri, July 15, 2022

Filed a patent for "spray dried extract" on Mon, August 8, 2022

Filed a patent for "interleukin-18 variants and uses thereof" on Fri, August 26, 2022

Filed a patent for "anti-cd3 antibodies, compositions comprising anti-cd3 antibodies and methods of making and using anti-cd3 antibodies" on Thu, September 29, 2022

Filed a patent for "anti-folate receptor conjugate therapy for pediatric acute myeloid leukemia" on Fri, October 21, 2022

Filed a patent for "anti-ror1 antibody conjugates, compositions comprising anti ror1 antibody conjugates, and methods of making and using anti-ror1 antibody conjugates" on Thu, November 3, 2022

Filed a patent for "interferon alpha polypeptides and conjugates" on Fri, November 4, 2022

Filed a patent for "interleukin-18 variants and uses thereof" on Fri, November 4, 2022

Filed a patent for "bispecific antibody-drug conjugates targeting egfr and muc1 and uses thereof" on Thu, October 5, 2023

Filed a patent for "modified amino acids" on Thu, May 4, 2023

Filed a patent for "anti-folate receptor conjugate therapy for pediatric acute myeloid leukemia" on Wed, February 1, 2023

Filed a patent for "anti-ror1 antibody conjugates, compositions comprising anti ror1 antibody conjugates, and methods of making and using anti-ror1 antibody conjugates" on Wed, March 1, 2023

Filed a patent for "anti-ror1 antibody conjugates, compositions comprising anti ror1 antibody conjugates, and methods of making and using anti-ror1 antibody conjugates" on Mon, March 13, 2023

Filed a patent for "interferon alpha polypeptides and conjugates" on Fri, March 31, 2023

Filed a patent for "interleukin-18 variants and uses thereof" on Fri, March 31, 2023

Filed a patent for "anti-ror1 antibody conjugates, compositions comprising anti ror1 antibody conjugates, and methods of making and using anti-ror1 antibody conjugates" on Wed, April 12, 2023